Table 2. Primers used in this study.
Name | Sequence (5’ → 3’) | RE site |
---|---|---|
sesCFs sesCF | ATGTCGACTTTATTAAAGGAGTATGTGTAAATG | SalI |
sesCR | ATCCCGGGTGATGATGCCTATTACTATATATAA | SmaI |
sesKF | ATGTCGACGACCTCTTAACTAATTATGTTATG | SalI |
sesKR | ATCCCGGGTCTCGTTATTTTCACTCAAATATC | SmaI |
(Underlined sequences: restriction sites; bold sequence: start codon)